News and Events

AMSL Diabetes launches Control-IQ Technology Update for the t:slim X2 Insulin Pump in Australia

Posted Apr 1, 2022.

AMSL Diabetes is excited to announce the launch of Control-IQ technology for the t:slim X2 insulin pump!

The t:slim X2 insulin pump (compatible with Dexcom G6 continuous glucose monitoring) is capable of remote feature updates.* Recently, we welcomed the newest software to launch within Australia; Control-IQ technology for the t:slim X2 insulin pump.

Control-IQ technology is an advanced hybrid closed-loop technology that helps to keep glucose levels in range^ (3.9 to 10 mmol/L) by predicting glucose levels 30 minutes ahead and adjusting insulin delivery according, to help prevent both high and low glucose events.

You can expect the same features from the t:slim X2 insulin pump with Control-IQ technology, such as the large colour touchscreen, slim design, rechargeable battery and micro-delivery™ technology.  Plus the following NEW features: 

  • NEW Automatic Insulin Adjustments – Based on readings from Dexcom G6 CGM
  • NEW Correction Boluses – Delivering automatic correction boluses (up to one an hour) to help prevent hyperglycaemia
  • NEW Activity Settings – Optional settings for Sleep and Exercise that adjust range of treatment values for more control

For existing t:slim X2 insulin pump users, you will receive communication from AMSL Diabetes with more information with your steps to updating your pump software.

For individuals who wish to start pumping, the t:slim X2 insulin pump can now also be purchased with Control-IQ software installed. We would recommend speaking to your healthcare professional to start this process.

For more information on this announcement, contact AMSL Diabetes on 1300 851 056 or email

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on before purchasing. Consult your healthcare professional to see which product is right for you.

About AMSL Diabetes

AMSL Diabetes is dedicated to helping people live well with diabetes. For over 20 years, AMSL Diabetes has given thousands of people the tools and support they need to improve their quality of life. AMSL Diabetes provides a range of diabetes products to individuals living with diabetes and the healthcare professionals that support them including t:slim X2 Insulin Pumps, Dexcom CGM Systems, OneTouch Blood Glucose Systems and other diabetes accessories. For more information, visit

*Additional feature updates are subject to future regulatory approvals. Charges may apply. Updates only available for insulin pumps within warranty.
^As measured by CGM
Dexcom G6 is sold separately
If glucose values are predicted to be above 10.0 mmol/L, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 6.1 mmol/L and delivers 60% of that value. An Automatic Correction Bolus will not occur within 60 minutes of a bolus that has been delivered or cancelled.